Blood Collection Tubes Market 2026: Size, Trends & Latest News

The blood collection tubes market is growing steadily as hospitals, diagnostic labs and clinics run more tests every year. These tubes are the first step in almost every blood test, so any change in demand, supply or safety affects the whole diagnostic chain. This guide covers market size, growth drivers, trends, leading companies and the latest industry news.
Blood Collection Tubes Market Size and Forecast
According to The Business Research Company, the blood collection tubes market was worth about $6.87 billion in 2025. It is estimated at $7.45 billion in 2026 (roughly 8.4% growth) and is forecast to reach $10.49 billion by 2030, a compound annual growth rate of 8.9%.
Estimates differ between research firms because each defines the market differently. For example, other publishers size only vacuum tubes or the wider vacuum blood collection device segment and report lower totals over longer periods. Treat all of these figures as directional, not exact.
Key Growth Drivers
- Chronic disease testing: Diabetes, cardiovascular disease and cancer need regular blood monitoring, which raises tube consumption.
- Lab automation: Automated analysers work best with barcoded, standardised, automation-compatible tubes.
- Outpatient and ambulatory care: More testing is happening outside hospitals, in clinics, diagnostic centres and surgical centres.
- Sample integrity: Labs want fewer contaminated or compromised samples, which pushes demand for better-engineered tubes.
Blood Collection Tubes Market Segmentation
The market is usually split in three ways:
- By product type: serum separating tubes, plasma separating tubes, heparin tubes, EDTA tubes and rapid serum tubes.
- By material: glass and plastic. Plastic is gaining share because it is lighter and less likely to break.
- By end user: hospitals, clinics, ambulatory surgical centres and others.
North America was the largest region in 2025, while Asia-Pacific is expected to grow fastest.
Trends Shaping the Industry
Plastic and pre-labelled tubes. Manufacturers are moving from glass to plastic and offering pre-labelled, colour-coded tubes to reduce handling errors.
Advanced preservation tubes. Newer tubes keep blood biomarkers stable for longer. Streck, for example, launched its Protein Plus BCT in April 2024 to preserve plasma proteins at room temperature. A preprint posted on medRxiv this month found that P100 tubes with protease inhibitors performed comparably to standard EDTA tubes across 127 neurodegeneration biomarkers. That supports remote sample collection for Alzheimer’s-related research. It is a preprint, so it has not yet been peer reviewed.
Local manufacturing in India. Husky Technologies’ integrated ICHOR moulding system is now used in India, and Kriya Medical Technologies has set up a fully automated line near Chennai with a stated capacity of about 250 million tubes a year. This fits India’s push for domestic medical device production.
Leading Companies
Major players include Becton Dickinson (BD), Greiner Bio-One, Sarstedt, Terumo, Sekisui, Nipro and FL Medical. Indian and Asian manufacturers such as CML Biotech, Poly Medicure, Hindustan Syringes, Narang Medical and Weigao are expanding their share.
Latest News: Supply Issues and Recalls
Supply remains a sensitive point for this market.
- Shortage background: The US FDA added all blood collection tubes to its device shortage list in January 2022 and published conservation strategies for labs.
- June 2026 supply hold: AABB reported that a large manufacturer briefly placed a corporate hold on essential blood collection products. It was released within days, and blood collection was not affected.
- Recalls: The FDA lists an open Class 2 recall of SAFE-T-FILL micro capillary tubes (Z-0372-2026). Separate Class II recalls of SAFE-T-FILL capillary tubes by ASP Global, cited for an inadequate quality system, were still ongoing at last check.
What This Means for Buyers and Labs
Because only a few manufacturers dominate supply, labs benefit from qualifying more than one supplier and watching FDA recall notices. If you are comparing products, see our guide to choosing the right blood collection tube and our overview of laboratory consumables.
Conclusion
The blood collection tubes market looks set for steady growth through 2030, driven by chronic disease testing, automation and stronger demand in Asia-Pacific. Recalls and supply holds are a reminder that quality control and supplier diversity matter as much as price.
Sources: The Business Research Company, AABB, US FDA, CAP, medRxiv, IMARC Group.
Frequently Asked Questions.
Q.How fast is the blood collection tubes market growing?
- The market is forecast to grow at a compound annual growth rate of about 8.9% between 2026 and 2030. Rising diagnostic testing, lab automation and outpatient care are the main reasons.
Q.Which region leads the blood collection tubes market?
- North America was the largest region in 2025. Asia-Pacific is expected to be the fastest-growing region through 2030, helped by local manufacturing in countries such as India and China.
Q.What is driving demand for blood collection tubes?
- The main drivers are the rising number of chronic disease patients who need regular blood tests, wider use of automated laboratory systems, growth of outpatient and ambulatory testing, and the need for contamination-free, reliable samples.
Q.What are the main types of blood collection tubes?
- The main types are serum separating tubes, plasma separating tubes, heparin tubes (lithium or sodium), EDTA tubes (K2 or K3) and rapid serum tubes. They are colour-coded by additive and the test they are used for.
Q.Are plastic or glass blood collection tubes more common?
- Plastic tubes are gaining share because they are lighter, break less easily and work well with automated pre-analytical systems. Glass tubes are still used where specific lab protocols require them.
Q.Who are the leading blood collection tube manufacturers?
- Major manufacturers include Becton Dickinson (BD), Greiner Bio-One, Sarstedt, Terumo, Sekisui, Nipro and FL Medical. Asian and Indian companies such as CML Biotech, Poly Medicure, Hindustan Syringes, Narang Medical and Weigao are also expanding.
Q.Is there a shortage or recall of blood collection tubes right now?
- The US FDA added all blood collection tubes to its device shortage list in January 2022. In June 2026 a manufacturer briefly placed a hold on some blood collection supplies, which was lifted within days without affecting collections. The FDA also lists open recalls for certain SAFE-T-FILL capillary tubes. Check the FDA shortage and recall databases for the latest status before purchasing.
Looking for Diagnostic Solutions?
Connect with our technical team for institutional supplies and clinical product inquiries.
